Framework agreement for multigene testing in localized breast cancer for prognostic and predictive therapeutic assessment in Pathology

01

The tender concerns a framework agreement for the provision of multigene testing for patients with localized breast cancer. The testing aims to provide prognostic and predictive therapeutic assessment and will be managed by the Pathology service. The buyer is the Inspección General de Sanidad de la Defensa. The estimated contract value is 110000 EUR. The current status of the tender is published. Small businesses capable of supplying these multigene tests may consider participating in this public procurement process.

02

Description

03

11 open tenders right now

• Framework Agreement for Healthcare Assistance Services for the Sahrawi Population Holding the Health Assistance Card 28 Sep 2026 · 1 day left
• Health services - Framework agreement for healthcare services for the Sahrawi population holding a healthcare assistance card 28 Sep 2026 · 1 day left
• Repair and maintenance services of building equipment - Maintenance of non-pharmaceutical equipment, infrastructure and installations CEMILFARDEF 30 Sep 2026 · 3 days left

Recent awards

• Adquisición de un sistema de suministro de oxígeno tópico para la Unidad de Heridas Complejas del Hospital General de la Defensa en Zaragoza (HGDZ)

  awarded to PALEX MEDICAL, S.A. €7,436

• Adquisición de ganado canino para asistencia a cursos, reposición para personal del Centro y dotación de nuevos guías del CEMILCANDEF

  awarded to JOSE ANTONIO VAZQUEZ MARTIN €12,600

• Adquisición botellas PET Cemilfar

  awarded to BIO SPIN CPF INSTRUMENTACION CIENTIFICA, S.L. €13,672

05

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€10,245,261

9,471 open across Europe right now 99% below sector average

Buyer track record on Aperlena

372 notices tracked · 289 awarded

€19,287,219 in awarded contracts